Skip to content

AbbVie ABBV Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

Cardinal Health logo
Cardinal HealthCAH
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
Incyte logo
IncyteINCY
Bausch Health Companies logo
Bausch Health CompaniesBHC
McKesson logo
McKessonMCK
Avalo Therapeutics logo
Avalo TherapeuticsAVTX

Other financials

Income statement

See full
Revenue$15.0B+12.4%
Gross profit$10.8B+15.4%
Operating income$4.0B+6.9%
Net income$695.0M-46.0%
EPS (diluted)$0.39-45.8%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation

See full
Market cap$444.6B+34.7%
P/E122.3×+34.6×
P/S7.1×+1.4×

Profitability

See full
Gross margin70.7%0.0pp
Operating margin24.4%
Net margin5.8%-1.5pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbbVie's common stock, shares issued (in shares)?
AbbVie (ABBV) reported common stock, shares issued (in shares) of 1.8B in Q1 2026.
How has AbbVie's common stock, shares issued (in shares) changed year-over-year?
AbbVie's common stock, shares issued (in shares) increased by 0.4% year-over-year, from 1.8B to 1.8B.
What is the long-term trend for AbbVie's common stock, shares issued (in shares)?
Over 5 years (2020 to 2025), AbbVie's common stock, shares issued (in shares) has grown at a 0.5% compound annual growth rate (CAGR), from 1.8B to 1.8B.